Clinical trial
Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy
NCT03420482 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- April 1, 2018
- Completion date
- January 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.